Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
ENTX compared with ELTX: revenue, margins and what each company keeps, and the suppliers and customers both name
ENTX
Entera Bio Ltd.
Change
Mkt cap
Revenue
Revenue
ELTX
Elicio Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
ENTX
Entera Bio Ltd.
vs
ELTX
Elicio Therapeutics, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
ENTX
Entera Bio Ltd.
Change
3.21
▲
+2.88%
· post 3.21
Mkt cap
$161.4M
Revenue
$42,000
Q1 FY25
ELTX
Elicio Therapeutics, Inc.
Change
1.69
▼
−3.18%
· post 1.69
Closed
Oct 30 '26
Mkt cap
$44.2M
Revenue
—
vs
Compare
Closed
Oct 30 '26
ENTX
Entera Bio Ltd.
vs
ELTX
Elicio Therapeutics, Inc.
3.21
▲
+2.88%
post 3.21
Price
1.69
▼
−3.18%
post 1.69
$161.4M
Mkt cap
$44.2M
Q1 FY25
$42,000
Revenue
—
Change
Change
ENTX
3.21
▲
+2.88%
vs
ELTX
1.69
▼
−3.18%
Closed
Oct 30 '26
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
ENTX, solid
ELTX, dashed
Supply-chain overlap
Revenue flow
ENTX: latest quarter is a loss; flow not drawable. ELTX: latest quarter not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only ENTX
1
OPK
OPKO Health
supplier
Shared
0
No shared counterparties.
Only ELTX
6
—
Dr. Roberto Chiarle
unlisted
supplier
—
Gastro-Intestinal ("GI") Research Foundation
unlisted
supplier
—
Massachusetts Institute of Technology ("MIT")
unlisted
supplier
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
—
Memorial Sloan Kettering Cancer Center
unlisted
supplier
2 more · ELTX chain
›